OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy
Elnaz Rouzbahani, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113906-113906
Open Access | Times Cited: 46
Elnaz Rouzbahani, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113906-113906
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
Xianjing Chu, Wentao Tian, Ziqi Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
Xianjing Chu, Wentao Tian, Ziqi Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Advances in dendritic cell vaccination therapy of cancer
Sajad Najafi, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114954-114954
Open Access | Times Cited: 53
Sajad Najafi, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114954-114954
Open Access | Times Cited: 53
Extracellular vesicle–based drug delivery in cancer immunotherapy
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 11, pp. 2790-2806
Open Access | Times Cited: 38
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 11, pp. 2790-2806
Open Access | Times Cited: 38
microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance
Mehdi Fattahi, Saeid Shahrabi, Fatemeh Saadatpour, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 125863-125863
Closed Access | Times Cited: 38
Mehdi Fattahi, Saeid Shahrabi, Fatemeh Saadatpour, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 125863-125863
Closed Access | Times Cited: 38
Silicon switch: Carbon–silicon Bioisosteric replacement as a strategy to modulate the selectivity, physicochemical, and drug‐like properties in anticancer pharmacophores
Jean Fotie, Caitlyn M. Matherne, Jordan E. Wroblewski
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 235-254
Closed Access | Times Cited: 31
Jean Fotie, Caitlyn M. Matherne, Jordan E. Wroblewski
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 235-254
Closed Access | Times Cited: 31
The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154729-154729
Open Access | Times Cited: 30
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154729-154729
Open Access | Times Cited: 30
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance
Mehdi Fattahi, Delsuz Rezaee, Fatemeh Fakhari, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Mehdi Fattahi, Delsuz Rezaee, Fatemeh Fakhari, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy
Mia C. Borlongan, Dipongkor Saha, Hongbin Wang
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 3-24
Closed Access | Times Cited: 17
Mia C. Borlongan, Dipongkor Saha, Hongbin Wang
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 3-24
Closed Access | Times Cited: 17
Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies
Qi Li, Guangpeng He, Yifan Yu, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Qi Li, Guangpeng He, Yifan Yu, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Targeting hypoxic and acidic tumor microenvironment by nanoparticles: A review
Mohamed J. Saadh, Mohammed Ahmed Mustafa, Laith Yassen Qassem, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105660-105660
Closed Access | Times Cited: 7
Mohamed J. Saadh, Mohammed Ahmed Mustafa, Laith Yassen Qassem, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105660-105660
Closed Access | Times Cited: 7
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
International Immunopharmacology (2023) Vol. 118, pp. 110032-110032
Closed Access | Times Cited: 16
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
International Immunopharmacology (2023) Vol. 118, pp. 110032-110032
Closed Access | Times Cited: 16
The impact of hypoxia on extracellular vesicle secretome profile of cancer
Keywan Mortezaee, Jamal Majidpoor
Medical Oncology (2023) Vol. 40, Iss. 5
Closed Access | Times Cited: 16
Keywan Mortezaee, Jamal Majidpoor
Medical Oncology (2023) Vol. 40, Iss. 5
Closed Access | Times Cited: 16
Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
Sajad Najafi, Keywan Mortezaee
Life Sciences (2023) Vol. 338, pp. 122387-122387
Closed Access | Times Cited: 16
Sajad Najafi, Keywan Mortezaee
Life Sciences (2023) Vol. 338, pp. 122387-122387
Closed Access | Times Cited: 16
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance
Qiuzhi Gao, Yixiang Zhan, Li Sun, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2141-2154
Closed Access | Times Cited: 15
Qiuzhi Gao, Yixiang Zhan, Li Sun, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2141-2154
Closed Access | Times Cited: 15
Transforming growth factor‐β signalling in tumour resistance to the anti‐PD ‐(L)1 therapy: Updated
Keywan Mortezaee, Jamal Majidpoor
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 311-321
Open Access | Times Cited: 14
Keywan Mortezaee, Jamal Majidpoor
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 311-321
Open Access | Times Cited: 14
Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors
Ting Yan, Yu Lun, Dangang Shangguan, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109638-109638
Open Access | Times Cited: 21
Ting Yan, Yu Lun, Dangang Shangguan, et al.
International Immunopharmacology (2022) Vol. 115, pp. 109638-109638
Open Access | Times Cited: 21
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategies
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
FAK downregulation suppresses stem-like properties and migration of human colorectal cancer cells
Chunyan Xu, Wenlu Zhang, Chengxia Liu
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284871-e0284871
Open Access | Times Cited: 11
Chunyan Xu, Wenlu Zhang, Chengxia Liu
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284871-e0284871
Open Access | Times Cited: 11
Role of cancer stem cell-derived extracellular vesicles in cancer progression and metastasis
Andarz Fazlollahpour‐Naghibi, Danyal Daneshdoust, Seyed Reza Taha, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154558-154558
Closed Access | Times Cited: 11
Andarz Fazlollahpour‐Naghibi, Danyal Daneshdoust, Seyed Reza Taha, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154558-154558
Closed Access | Times Cited: 11
Alternative immune checkpoints in immunoregulatory profile of cancer stem cells
Keywan Mortezaee, Jamal Majidpoor
Heliyon (2023) Vol. 9, Iss. 12, pp. e23171-e23171
Open Access | Times Cited: 11
Keywan Mortezaee, Jamal Majidpoor
Heliyon (2023) Vol. 9, Iss. 12, pp. e23171-e23171
Open Access | Times Cited: 11
UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST
Diana Odhiambo, Shuangyi Fan, Angela C. Hirbe
Cancers (2025) Vol. 17, Iss. 2, pp. 161-161
Open Access
Diana Odhiambo, Shuangyi Fan, Angela C. Hirbe
Cancers (2025) Vol. 17, Iss. 2, pp. 161-161
Open Access
Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy
Tao‐Wei Ke, Chia-Yi Chen, William Tzu‐Liang Chen, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Tao‐Wei Ke, Chia-Yi Chen, William Tzu‐Liang Chen, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Liquid biopsy in colorectal cancer
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Clinica Chimica Acta (2023) Vol. 553, pp. 117674-117674
Closed Access | Times Cited: 10
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Clinica Chimica Acta (2023) Vol. 553, pp. 117674-117674
Closed Access | Times Cited: 10
